James Williams, DO
Emergency Medicine · San Antonio, TXNPI 1376582031
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $254,683 of the $359,801 with a category attached, or 70.8%. AstraZeneca accounts for 62.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $191,173 and has fallen 100.0% since, to $14 in 2025. Among emergency medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $1090.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$223K
- Johnson & Johnson$102K
- Eagle Pharmaceuticals, Inc.$11K
- Portola Pharmaceuticals, LLC$9K
- Boehringer Ingelheim$8K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$5K
- plus $2K from 8 others
Across 8 payments — averaging $945.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$8K
What the payments were for
- Consulting fees$38,76911%
- Speaking & faculty fees$254,68371%
- Travel & lodging$58,96216%
- Food & beverage$7,3882%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 183 | $223,050 |
| Johnson & Johnson | 97 | $102,093 |
| Eagle Pharmaceuticals, Inc. | 12 | $10,753 |
| Portola Pharmaceuticals, LLC | 6 | $8,622 |
| Boehringer Ingelheim | 8 | $8,367 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $4,817 |
| Instrumentation Laboratory Company | 1 | $800 |
| BTG International Inc. | 6 | $779 |
| Quidel Corporation | 1 | $200 |
| Abbott | 2 | $144 |
| Merz North America, Inc. | 1 | $73 |
| Fisher Scientific Company L.L.C. | 1 | $70 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$359,801 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other emergency medicine in San Antonio
- Christine ZinkSan Antonio$27K
- Robert WigginsSan Antonio$21K
- Robert RyanSan Antonio$19K
- David MiramontesSan Antonio$11K
- Craig GoolsbySan Antonio$7K
- David StachniakSan Antonio$6K
- Gregory YuSan Antonio$6K
- John McKinneyTyler$1.9M
- William PeacockHouston$513K
- Myiesha TaylorSunnyvale$369K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.